Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study Options for single-agent ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor, nurse or pharmacist. DBL Fluorouracil Injection BP contains the active ingredient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback